ZW3579A1 - Solubilization of insoluble drugs - Google Patents
Solubilization of insoluble drugsInfo
- Publication number
- ZW3579A1 ZW3579A1 ZW35/79A ZW3579A ZW3579A1 ZW 3579 A1 ZW3579 A1 ZW 3579A1 ZW 35/79 A ZW35/79 A ZW 35/79A ZW 3579 A ZW3579 A ZW 3579A ZW 3579 A1 ZW3579 A1 ZW 3579A1
- Authority
- ZW
- Zimbabwe
- Prior art keywords
- solubilization
- insoluble drugs
- drugs
- insoluble
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/609—Amides, e.g. salicylamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/876,968 US4128632A (en) | 1978-02-13 | 1978-02-13 | Solubilization of Rafoxanide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZW3579A1 true ZW3579A1 (en) | 1980-09-10 |
Family
ID=25368975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZW35/79A ZW3579A1 (en) | 1978-02-13 | 1979-02-09 | Solubilization of insoluble drugs |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4128632A (it) |
| EP (1) | EP0003682B1 (it) |
| JP (1) | JPS54117019A (it) |
| AR (1) | AR221862A1 (it) |
| AT (1) | AT363600B (it) |
| AU (1) | AU522422B2 (it) |
| DE (1) | DE2962602D1 (it) |
| DK (1) | DK57479A (it) |
| HU (1) | HU177873B (it) |
| IE (1) | IE47833B1 (it) |
| IT (1) | IT1113720B (it) |
| NZ (1) | NZ189536A (it) |
| OA (1) | OA06239A (it) |
| PH (1) | PH13191A (it) |
| PL (1) | PL114317B1 (it) |
| YU (1) | YU25679A (it) |
| ZA (1) | ZA79597B (it) |
| ZW (1) | ZW3579A1 (it) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2525108B1 (fr) * | 1982-04-19 | 1989-05-12 | Elan Corp Ltd | Medicaments a haut degre de solubilite et procede pour leur obtention |
| US4933360A (en) * | 1983-03-16 | 1990-06-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Novel chlorthalidone process and product |
| YU43349B (en) * | 1983-03-16 | 1989-06-30 | Boehringer Ingelheim Ltd | Process for making a watersoluble, pharmaceutically acceptible dispersion of chlortalidone in solid state |
| EP0305384A4 (en) * | 1986-05-02 | 1989-06-13 | Gaf Corp | WATER-SOLUBLE POLYVINYL LACTAM MEDICINE COMPLEXES. |
| FR2640137A1 (fr) * | 1988-12-08 | 1990-06-15 | Texinfine Sa | Systemes transporteurs de principes actifs lipophiles et leur procede d'obtention |
| EP1129713A1 (en) * | 2000-02-29 | 2001-09-05 | New Pharma Research Sweden AB | Veterinary compositions for the treatment of parasitic diseases |
| GB2386066A (en) * | 2002-02-28 | 2003-09-10 | Norbrook Lab Ltd | Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species |
| DE102010051404B4 (de) | 2010-11-16 | 2017-08-31 | Marc de Cocq | Verwendung von substituierten Salicylaniliden zur Behandlung von Fischen |
| DE102012009572A1 (de) | 2012-05-15 | 2013-11-21 | Marc de Cocq | Die Verwendung von Glycerol-Formal als Lösungsvermittler für pharmazeutische Wirkstoffe bei der Bekämpfung von Fischkrankheiten |
| CN106176586A (zh) * | 2016-07-22 | 2016-12-07 | 柳州市柳南区安顺养殖协会 | 一种牛羊用抗寄生虫病碘醚柳胺透皮溶液 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL184257C (nl) * | 1974-06-19 | 1989-06-01 | Merck & Co Inc | Werkwijze voor het bereiden van rafoxanide preparaten. |
-
1978
- 1978-02-13 US US05/876,968 patent/US4128632A/en not_active Expired - Lifetime
-
1979
- 1979-02-01 PH PH22153A patent/PH13191A/en unknown
- 1979-02-01 NZ NZ189536A patent/NZ189536A/xx unknown
- 1979-02-05 AR AR275403A patent/AR221862A1/es active
- 1979-02-05 AU AU43914/79A patent/AU522422B2/en not_active Ceased
- 1979-02-06 YU YU00256/79A patent/YU25679A/xx unknown
- 1979-02-06 HU HU79ME2247A patent/HU177873B/hu unknown
- 1979-02-08 IT IT47942/79A patent/IT1113720B/it active
- 1979-02-09 EP EP79300202A patent/EP0003682B1/en not_active Expired
- 1979-02-09 ZW ZW35/79A patent/ZW3579A1/xx unknown
- 1979-02-09 DE DE7979300202T patent/DE2962602D1/de not_active Expired
- 1979-02-10 PL PL1979213352A patent/PL114317B1/pl unknown
- 1979-02-12 AT AT0106679A patent/AT363600B/de not_active IP Right Cessation
- 1979-02-12 DK DK57479A patent/DK57479A/da not_active Application Discontinuation
- 1979-02-12 IE IE259/79A patent/IE47833B1/en unknown
- 1979-02-12 ZA ZA79597A patent/ZA79597B/xx unknown
- 1979-02-13 JP JP1441279A patent/JPS54117019A/ja active Pending
- 1979-04-19 OA OA56790A patent/OA06239A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL213352A1 (it) | 1979-12-03 |
| ATA106679A (de) | 1981-01-15 |
| EP0003682A1 (en) | 1979-08-22 |
| US4128632A (en) | 1978-12-05 |
| JPS54117019A (en) | 1979-09-11 |
| OA06239A (fr) | 1981-06-30 |
| IE47833B1 (en) | 1984-06-27 |
| IT7947942A0 (it) | 1979-02-08 |
| HU177873B (en) | 1982-01-28 |
| DE2962602D1 (en) | 1982-06-09 |
| EP0003682B1 (en) | 1982-04-28 |
| AU522422B2 (en) | 1982-06-03 |
| NZ189536A (en) | 1981-02-11 |
| IE790259L (en) | 1979-08-13 |
| PH13191A (en) | 1980-01-16 |
| ZA79597B (en) | 1980-10-29 |
| IT1113720B (it) | 1986-01-20 |
| DK57479A (da) | 1979-08-14 |
| AU4391479A (en) | 1979-08-23 |
| AR221862A1 (es) | 1981-03-31 |
| PL114317B1 (en) | 1981-01-31 |
| AT363600B (de) | 1981-08-10 |
| YU25679A (en) | 1984-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2085732B (en) | Administration set | |
| ZA793542B (en) | Pharmaceutical preparations | |
| AU4213878A (en) | Administration of antihistamines | |
| GB2028336B (en) | Steroid hormone-antitumour drug conjugates | |
| NZ189378A (en) | 4-amino-5-alkylsulphonyl-ortho-anisamdes and pharmaceutical compositions | |
| JPS54145645A (en) | *mmbenzoyllphenoxy**22propionic acid derivative and medicine | |
| NZ190784A (en) | Benzofuranyl-piperidines and pharmaceutical compositions | |
| JPS55147223A (en) | Pharmaceutical medicine | |
| JPS5528986A (en) | Novel administration form | |
| ZA796549B (en) | New pharmaceutical preparations | |
| ZA787000B (en) | Pharmaceutical formulation | |
| ZA79597B (en) | Solubilization of insoluble drugs | |
| NZ191102A (en) | Pharmaceutical formulations of galactomannan | |
| GB2038838B (en) | Immunogen conjugates of diphenyldantoin | |
| PH18056A (en) | Pharmaceutical formulations of cisplatin | |
| JPS54132563A (en) | Corticosteroid antiiinflammatry drug | |
| ZA793923B (en) | Medicinal formulation | |
| JPS5524175A (en) | Agricultural drug | |
| GB2039277B (en) | Preparation of pharmacologically-active piperidylindoles | |
| JPS54138116A (en) | Medical constituent of mannentake | |
| JPS54135795A (en) | Diuretic drug | |
| NZ189279A (en) | Arylaminoimidazolines and pharmaceutical compositions | |
| JPS5547660A (en) | Thio substituted diazacycloalkene*its its manufacture and drug | |
| JPS54130586A (en) | 55fluorouracil derivative*its manufacture and drug containing it | |
| JPS5527168A (en) | Drug composition |